Key data
Open—
From 52W high—
Volume—
Market cap—
P/E (TTM)—
P/S (TTM)—
Div yield—
Key data
Open
—
From 52W high
—
Volume
—
Market cap
—
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
—
P/E (TTM)
—
RSI (14)
—
MomentumView details →
1D Return
—
YTD Return
—
Latest newsMore news →
Daiko Pharmaceutical announced on August 25 that it will apply to change its market segment from the Tokyo Stock Exchange Prime Market to the Standard Market, because its free-float market capitalization fell below the Prime maintenance standard.26d agoTaiko Pharmaceutical reported a 2.1-fold increase in recurring profit for the first half and a 15-fold increase for the April-June quarter.38d ago